Blood Product Administration



Blood Product Administration









CHILD AND FAMILY ASSESSMENT AND PREPARATION



  • Assess the cognitive level, readiness, and ability to process information of the child and family.


  • Explain the procedure and the reason for blood administration to the child and family, which may help reduce anxiety related to receiving blood products. Provide the child and family with educational materials regarding transfusion.


  • Identify the child’s and family’s religious beliefs and discuss the religious justification and ramifications associated with blood transfusion; some religions prohibit blood transfusion, so be sure to elicit the family’s views.


  • Discuss the risks and benefits of blood product administration with child and family.


  • Review and confirm child’s medical history, including any known allergies.


  • Assess the child’s transfusion history for the presence of transfusion-related reactions. A direct relationship exists between the number of transfusions the patient has had and the likelihood of having a transfusion reaction. If the child has had previous transfusion reactions, question the child and family about which pretransfusion medications most effectively reduced symptoms in the child. Current evidence does not support the efficacy of premedication with diphenhydramine in preventing allergic reaction (Duran et al., 2014).


  • Assess the child’s vital signs (temperature, heart rate, respiratory rate, blood pressure), oxygen saturation level of comfort, and laboratory values (including electrolytes) to establish a pretransfusion baseline.


  • Assess need for use of blood warmer in infants, in children who are hypothermic, and in children in whom large amounts of blood are to be transfused.


  • Obtain written consent for blood product administration from the parent/guardian or child, if emancipated.












TABLE 21-1 Blood Product Administration Guidelines












































































































































Component


Description


Indication


Type of Filter


Dose


Rate


Administration


Special Considerations


Whole blood


Single-donor anticoagulated blood


Massive blood loss Exchange transfusion Special procedures (ECMO or CRRT to prime the circuit, apheresis)


170 micron filter


Massive blood loss—20 mL/kg initially


Exchange transfusion: two times child’s blood volume


As rapidly as necessary to reestablish blood volume


45-60 minutes (longer if he-modynamically unstable)



Always administer ABO group and Rh-type specific


In an emergency administer O-negative uncrossmatched blood.


Packed red blood cells


Concentrated red blood cells with most plasma, leukocytes, and platelets removed


Severe anemia


Surgical blood loss Suppression of erythropoiesis (e.g., thalassemia or sickle cell anemia)


ECMO—blood loss from bleeding or multiple sampling for laboratory analysis


170 micron filter


5 mL/kg/hour


10 mL/kg



Administer ABO group and Rh-type specific if possible. If not, group and type compatible can be transfused safely. May use O-negative uncrossmatched blood for infants up to 4 months of age


Red blood compatibility:









Recipient


Donor









A


B


AB


O


Rh+


Rh−


Undetermined


A, O


B, O


AB, A, B, O


O


Rh+


Rh−


O


Saline-washed red blood cells


Red blood cells washed with normal saline, which removes 80% leukocytes


Children with history of repeated febrile transfusion reactions


Immunocompromised patients


Same as packed red blood cells


Same as packed red blood cells


Same as packed red blood cells



Same as packed red blood cells


Frozen deglycerolized red blood cells


Specially processed red blood cells that can be stored for up to 3 years


Rare blood types History of repeated febrile nonhemolytic reactions not responsive to other leukocyte depletion methods


Immunoglobulin A (IgA) deficiency with sensitivity to IgA


Same as packed red blood cells


Same as packed red blood cells


Same as packed red blood cells



Same as packed red blood cells


Albumin


A plasma protein available in 5% and 25% solutions


5% Solution: hypoproteinemia, volume deficits


25% Solution: severe burns, cerebral edema


Not all plasma protein require a filter, if filter is required, use the filter that comes with the product


5%: Hypoalbuminemia or hypovolemia 10 mL/kg per dose


25%: 1 g/kg = 4 mL/kg


5%: 1-2 mL/minute (60-120 mL/hour can be administered as fast as possible to correct shock)


25%: 0.2-0.4 mL/minute (12-24 mL/hour)



Needs no blood filter


Only one person must identify product and patient


Vital signs can be taken prn


Compatibility testing not required


25% Albumin rapidly mobilizes large volumes of fluid into circulation (therefore, watch for pulmonary edema or other symptoms of fluid overload)


Product is stored at room temperature and has very long shelf life


Check expiration date before administering


Fresh frozen plasma


Contains all the clotting factors and some fibrinogen


Massive hemorrhage Hypovolemic shock Multiple clotting deficiencies


170 micron filter


10-30 mL/kg


Hemorrhage—as indicated by patient’s condition Clotting deficiency—over 2-3 hours


Administer within 6 hours of thawing to preserve clotting factor activity


Donor’s plasma should be ABO compatible with recipient’s red blood cells.


Rh compatibility not required because product does not contain red blood cells.


Platelets


Platelets suspended in a small amount of plasma


Severe thrombocytopenia (platelet count <20,000)


Platelet count <50,000 in child who requires surgery or in child with hemorrhage or imminent bleeding


Cardiac surgery with massive blood replacement


Platelet count <80,000-100,000 in child undergoing ECMO or CRRT


170 micron filter


10 mL/kg or 1 random unit per year of age


Platelets may be given by IVP (5-10 minutes/U) if volume is a problem, transfuse total dose over 2-3 hours using infusion pump.


Gently agitate bag even more often (every hour) than other blood products because platelets tend to clump; if giving pooled random platelets or platelet aliquots, notify the blood bank 60 minutes before anticipated transfusion time to allow for special handling.


Must be Rh compatible; ABO plasma compatibility preferred


Available platelets include


• Random—different donors, not necessarily type specific


• Type specific—blood type is the same as recipient


• Single donor—pheresed platelets from single donor (1 pheresed platelet unit is equivalent to 8-10 random platelets)


• HLA-pheresed—HLA testing has been done and matched to the recipient’s HLA type.









Platelets may be irradiated to inactivate donor lymphocytes that cause graft versus host disease in immunocompromised patients.


Premedicate as ordered, if patient has a history of reaction.


If single-donor or HLA platelets are ordered, obtain a 1-hour and a 24-hour platelet count after transfusion to determine adequate platelet response.


Observe patient for transfusion reaction because platelets may be contaminated with some red blood cells.


Cryoprecipitate


A concentration of clotting factors VIII, XIII, fibrinogen and von Willebrand factor


Hemophilia A von Willebrand disease


Hypofibrinogenemia


Disseminated intravascular coagulation (DIC)


170 micron filter


One bag per 5 kg, for mild bleed


One bag per 2 kg, for severe life-threatening bleed


Repeat every 12-24 hours as necessary


May infuse as quickly as possible or be given by IVP


Each bag contains about 15 mL


Neonates: Use syringe to draw cryo through filter.


Infuse through syringe pump.


Administer within 6 hours of thawing.


Monitor vital signs as instructed


Administer ABO compatible Rh type (compatibility preferable, but not required).


Granulocytes


Infection-fighting white blood cells


Severe gram-negative infection or severe neutropenia unresponsive to routine forms of therapy in immunosuppressed patient


Severe granulocyte dysfunction


170 micron filter


10-15 mL/kg per dose


About 5 mL/kg/hour


Granulocyte product must be irradiated (if so ordered) and infused within 24 hours of donation, preferably within 6 hours of donation.


Type and crossmatch needed before transfusion


Mild fever and chills are a common reaction.


Compress blood bag to mix the white cells periodically throughout the transfusion.


Vital signs should be taken every 15 minutes × 4, then every hour during infusion.


Amphotericin cannot be administered for 6 hours before or after granulocyte transfusion.


Factor VIII concentrate


Sterile lyophilized powder containing the blood coagulation factor VIII, which is prepared from pooled human plasma


Hemophilia A


Filter needle provided with product


Minor bleed: 20 U/kg Severe bleed: 40 U/kg


Administer by IVP over about 5 minutes (2 mL/minute max). If patient complains of headache, slow the rate because product is high in protein.


Reconstitute product per manufacturer instructions. Withdraw solution from vial using filter needle, then administer through syringe.


Administer within 1 hour of reconstitution.


Dose is ordered in units.


No compatibility testing is required.


Children on long-term therapy, if other than type O, should be monitored for hemolysis caused by isoagglutinins (anti-A and anti-B antibodies).


Group-specific concentrates are available if needed.


Factor IX complex


Concentrated powdered blood coagulation factors II, VII, IX, and X


Congenital factor deficiency VII and X; acquired deficiency of factors II, VII, IX, and X


Filter needle provided with product



Administer by IVP over about 5 minutes.


Maximum rates: Monoclate = 2 mL/minute Humanate = 4 mL/minute Others = 10 mL/minute


Reconstitute product per manufacturer instructions. Withdraw solution from vial using filter needle, then administer through syringe.


No type or crossmatch required

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 9, 2020 | Posted by in NURSING | Comments Off on Blood Product Administration

Full access? Get Clinical Tree

Get Clinical Tree app for offline access